173 related articles for article (PubMed ID: 31117347)
1. An Albumin-Binding T
Zhou Z; Bai R; Wang Z; Bryant H; Lang L; Merkle H; Munasinghe J; Tang L; Tang W; Tian R; Yu G; Ma Y; Niu G; Gao J; Chen X
Bioconjug Chem; 2019 Jun; 30(6):1821-1829. PubMed ID: 31117347
[TBL] [Abstract][Full Text] [Related]
2. Dual T
Suárez-García S; Arias-Ramos N; Frias C; Candiota AP; Arús C; Lorenzo J; Ruiz-Molina D; Novio F
ACS Appl Mater Interfaces; 2018 Nov; 10(45):38819-38832. PubMed ID: 30351897
[TBL] [Abstract][Full Text] [Related]
3. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
[TBL] [Abstract][Full Text] [Related]
4. T
Zhou Z; Bai R; Munasinghe J; Shen Z; Nie L; Chen X
ACS Nano; 2017 Jun; 11(6):5227-5232. PubMed ID: 28613821
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment responsive
Liang M; Zhou W; Zhang H; Zheng J; Lin J; An L; Yang S
J Mater Chem B; 2023 May; 11(19):4203-4210. PubMed ID: 37114335
[TBL] [Abstract][Full Text] [Related]
6. PDGFB-targeted functional MRI nanoswitch for activatable T
Zhang Y; Liu L; Li W; Zhang C; Song T; Wang P; Sun D; Huang X; Qin X; Ran L; Tian G; Qian J; Zhang G
J Nanobiotechnology; 2023 Jan; 21(1):9. PubMed ID: 36609374
[TBL] [Abstract][Full Text] [Related]
7. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
Stokes AM; Semmineh N; Quarles CC
Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
[TBL] [Abstract][Full Text] [Related]
8. An Ultrahigh-Field-Tailored T
Wang J; Jia Y; Wang Q; Liang Z; Han G; Wang Z; Lee J; Zhao M; Li F; Bai R; Ling D
Adv Mater; 2021 Jan; 33(2):e2004917. PubMed ID: 33263204
[TBL] [Abstract][Full Text] [Related]
9. EDTMP ligand-enhanced water interactions endowing iron oxide nanoparticles with dual-modal MRI contrast ability.
Hao L; Wang P; Wu Z; Wang Z; Wang Y; Zhu Y; Xu Z; Guo M; Ji J; Zhang P
J Mater Chem B; 2021 Nov; 9(43):9055-9066. PubMed ID: 34673872
[TBL] [Abstract][Full Text] [Related]
10. High-Performance
Zhao D; Peng S; Xiao H; Li Q; Chai Y; Sun H; Liu R; Yao L; Ma L
ACS Appl Bio Mater; 2023 Jun; 6(6):2137-2144. PubMed ID: 37229527
[TBL] [Abstract][Full Text] [Related]
11. A pH-responsive T
Lu H; Chen A; Zhang X; Wei Z; Cao R; Zhu Y; Lu J; Wang Z; Tian L
Nat Commun; 2022 Dec; 13(1):7948. PubMed ID: 36572677
[TBL] [Abstract][Full Text] [Related]
12. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis.
Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956
[TBL] [Abstract][Full Text] [Related]
13. Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T1 weighting.
Nöth U; Hattingen E; Bähr O; Tichy J; Deichmann R
NMR Biomed; 2015 Jul; 28(7):818-30. PubMed ID: 25960356
[TBL] [Abstract][Full Text] [Related]
14. Core/shell Fe3O4/Gd2O3 nanocubes as T1-T2 dual modal MRI contrast agents.
Li F; Zhi D; Luo Y; Zhang J; Nan X; Zhang Y; Zhou W; Qiu B; Wen L; Liang G
Nanoscale; 2016 Jul; 8(25):12826-33. PubMed ID: 27297334
[TBL] [Abstract][Full Text] [Related]
15. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of contrast enhancement in magnetic resonance imaging.
Lee DH
Can Assoc Radiol J; 1991 Feb; 42(1):6-12. PubMed ID: 2001531
[TBL] [Abstract][Full Text] [Related]
17. The advantage of high relaxivity contrast agents in brain perfusion.
Cotton F; Hermier M
Eur Radiol; 2006 Nov; 16 Suppl 7():M16-26. PubMed ID: 18655263
[TBL] [Abstract][Full Text] [Related]
18. Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer.
Molinelli V; Angeretti MG; Duka E; Tarallo N; Bracchi E; Novario R; Fugazzola C
Abdom Radiol (NY); 2018 Nov; 43(11):2903-2912. PubMed ID: 29541831
[TBL] [Abstract][Full Text] [Related]
19. Imaging short-lived reactive oxygen species (ROS) with endogenous contrast MRI.
Tain RW; Scotti AM; Li W; Zhou XJ; Cai K
J Magn Reson Imaging; 2018 Jan; 47(1):222-229. PubMed ID: 28503732
[TBL] [Abstract][Full Text] [Related]
20. [HIRE (high intensity reduction). New cerebrospinal fluid suppressed T2-weighted imaging sequence].
Essig M; Deimling M; Schoenberg SO; Debus J; Knopp MV; van Kaick G
Radiologe; 2000 Dec; 40(12):1163-71. PubMed ID: 11197935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
